Morrison Briggs's Form 4 filing
Syndax Pharmaceuticals Inc (SNDX) · filed Jun 9, 2023
- Accession no.
- 0001562180-23-005057
- Filed
- Jun 9, 2023
- Trade date
- Jun 9, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.12M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morrison BriggsCIK 0001654430 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | Common Stock | MOption exerciseAcquired | +24,582 | $6.38 | +$156,833.16 | 42,418 | Direct | |
| Jun 9, 2023 | Common Stock | MOption exerciseAcquired | +28,273 | $8.77 | +$247,954.21 | 70,691 | Direct | |
| Jun 9, 2023 | Common Stock | SSaleDisposed | −24,582 | $21.18 | −$520,646.76 | 46,109 | Direct | |
| Jun 9, 2023 | Common Stock | SSaleDisposed | −28,273 | $21.18 | −$598,822.14 | 17,836 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | Common Stock | MOption exerciseDisposed | −28,273 | $0.00 | $0 | 0 | Direct | |
| Jun 9, 2023 | Common Stock | MOption exerciseDisposed | −24,582 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.